Subscribe

Main navigation

Home
Conferences
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Support

Search results

‘Taking the lid off the box’: The value of extended clinical assessment for adolescents presenting with gender identity difficulties

April 1, 2019
Studies

Clinicians explore alternative approaches to the "affirmative" paradigm for understanding and treating young people with gender dysphoria.

Transgender and Gender Diverse Children and Adolescents: Fact-Checking of AAP Policy

May 18, 2020
Studies

A clinician critiques a policy statement produced by the American Academy of Pediatrics, highlighting where relevant literature has been ignored, distorted or mis-represented.

Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices

May 1, 2025
Studies

Internationally, a growing number of European countries have retreated from the "gender-affirming treatment model" for children and adolescents due to concerns about a lack of evidence of benefits and increasing evidence of harms of these interventions. These developments have largely been...

Matched fragments:
… a child’s self-reported identity; puberty suppressing drugs to prevent the onset of puberty; cross-sex hormones to spur … banned the routine use of puberty blockers as an intervention for …

The Economist Coverage of the HHS Report on Gender Dysphoria

May 11, 2025
Spotlight
The summary cuts to the chase. “The evidence for benefit of paediatric medical transition is very uncertain, while the evidence for harm is less uncertain.” When medical interventions pose unnecessary, disproportionate risks of harm, “healthcare providers should refuse to offer them even when they...
Matched fragments:
… about the nationwide embrace of puberty blockers, cross-sex hormones and …

Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review

April 1, 2018
Studies

SEGM Summary:

Puberty blocking drugs seemed to improve psychological functioning (not mentioned: youth were also receiving psychotherapy) but did not alleviate gender dysphoria. Little is known about the psychosocial effects of giving young people puberty blockers or cross-sex hormones....

Matched fragments:
… SEGM Summary: Puberty blocking drugs seemed to … effects of giving young people puberty blockers or cross-sex hormones. …

Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones

December 1, 2020
Studies

This prospective but uncontrolled observational study investigated the effect of GnRH agonist therapy alone or with subsequent cross-sex hormone administration on markers of bone turnover, apparent bone density (BMAD) and bone density z-scores, with analysis of subjects started early (Tanner...

Matched fragments:
… This study confirmed that use of puberty blockers during normally timed puberty reduces bone turnover and …

Suicide Mortality Among Gender-Dysphoric Adolescents and Young Adults in Finland

February 23, 2024
Spotlight
Summary

A recent study published in BMJ Mental Health, All-cause and suicide mortalities among adolescents and young adults who contacted specialised gender identity services in Finland in 1996–2019, analyzed overall mortality...

Matched fragments:
… paper focused on the outcomes of puberty blockers ( de Vries et al., 2011 … Endocrine Society (i.e., starting puberty blockade at Tanner stage 2 …

6. Managing Gender Dysphoria in Youth: European Practice Changes

September 11, 2025
CME | Course

Over the past decade, Europe has undergone a paradigm shift in the care of gender-dysphoric youth. In December 2024, the UK indefinitely banned puberty blockers for gender dysphoria outside research trials, while Sweden, Finland, and Norway implemented significant restrictions between 2020 and...

Matched fragments:
… 2024, the UK indefinitely banned puberty blockers for gender dysphoria … low-certainty findings for puberty suppression, detransition …

Our Response to the Southern Poverty Law Center

September 5, 2025
Other

September 10, 2025

The Society for Evidence-Based Gender Medicine was established to promote evidence-based, ethical care for children, adolescents, and young adults with gender dysphoria. In recent years, politicized attacks on organizations and individual researchers working in this...

Matched fragments:
… reviews—into the use of puberty blockers , cross-sex hormones , and … for an end to prescription puberty blockers for trans kids”  is …

Reassessing the Trevor Project’s Suicide-Attempt Findings

June 16, 2026
Spotlight
A peer-reviewed critique challenges the Trevor Project’s claim that anti-trans laws caused up to a 72% increase in youth suicide attempts, highlighting Idaho’s central role.
Matched fragments:
… healthcare (for example, puberty blockers, hormone therapy and … in the UK that the country’s puberty-blocker ban caused a surge …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Page 13
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM